These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3558984)

  • 21. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
    Feldman AM; Becker LC; Llewellyn MP; Baughman KL
    Am Heart J; 1988 Sep; 116(3):771-7. PubMed ID: 3046278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    Feldman AM; Baughman KL; Lee WK; Gottlieb SH; Weiss JL; Becker LC; Strobeck JE
    Am J Cardiol; 1991 Nov; 68(11):1203-10. PubMed ID: 1951080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure.
    Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Schaefer HG; Mueck W; Bornemann M; Pouleur H
    J Am Coll Cardiol; 1997 Dec; 30(7):1751-7. PubMed ID: 9385903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents.
    Murali S; Uretsky BF; Reddy PS; Tokarczyk TR; Betschart AR
    Am Heart J; 1991 Nov; 122(5):1375-81. PubMed ID: 1951003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure.
    Kessler PD; Packer M
    Am Heart J; 1987 Jan; 113(1):137-43. PubMed ID: 3799427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
    Chatterjee K; Kereiakes D; Viquerat C; Podolin R
    Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
    Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
    Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
    Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.